Metabolic enzymes such as pyruvate kinase M2, fumarase, and pyruvate dehydrogenase complex translocate into the nucleus and have instrumental roles in the epigenetic regulation of gene expression and DNA repair [3][4][5] . KAT2A, a member of the GCN5-related N-acetyltransferase (GNAT) superfamily, was identified as a histone acetyltransferase (HAT) that binds to acetyl-CoA and transfers its acetyl group to histones 6,7 . Mass spectrometric analyses of immunoprecipitated KAT2A from human HEK-293 cells and U251 glioblastoma (GBM) cells identified several known KAT2A-associated proteins, such as histone H3, RAD50, and TAF6L (Supplementary Table 1) ; it also revealed that oxoglutarate dehydrogenase (OGDH) (Extended Data  Fig. 1a) , which is a component of the α -KGDH complex that catalyses the conversion of α -ketoglutarate (α -KG) to succinyl-CoA, interacts with KAT2A. In addition, immunoblotting analyses of immunoprecipitated endogenous KAT2A with antibodies against the three components of α -KGDH-OGDH, dihydrolipoyl succinyltransferase (DLST), and dihydrolipoyl dehydrogenase (DLD)-revealed that these endogenous proteins were associated with each other (Fig. 1a) . Cell fractionation (Fig. 1b, Extended Data Fig. 1b ) and immuno fluorescence (Extended Data Fig. 1c) analyses of U251 cells revealed that about 1-1.6% of total OGDH, DLST, and DLD was loca lized in the nucleus (Extended Data Fig. 1b) . About 13-16% of nuclear α -KGDH bound to KAT2A (Extended Data Fig. 1d, top) , whereas about 2.3% of KAT2A (Extended Data Fig. 1d, bottom) , which was found in nuclei but not in mitochondria (Extended Data Fig. 1e, f) , interacted with OGDH.
. Mass spectrometric analyses of immunoprecipitated KAT2A from human HEK-293 cells and U251 glioblastoma (GBM) cells identified several known KAT2A-associated proteins, such as histone H3, RAD50, and TAF6L (Supplementary Table 1) ; it also revealed that oxoglutarate dehydrogenase (OGDH) (Extended Data Fig. 1a ), which is a component of the α -KGDH complex that catalyses the conversion of α -ketoglutarate (α -KG) to succinyl-CoA, interacts with KAT2A. In addition, immunoblotting analyses of immunoprecipitated endogenous KAT2A with antibodies against the three components of α -KGDH-OGDH, dihydrolipoyl succinyltransferase (DLST), and dihydrolipoyl dehydrogenase (DLD)-revealed that these endogenous proteins were associated with each other (Fig. 1a) . Cell fractionation (Fig. 1b, Extended Data Fig. 1b ) and immuno fluorescence (Extended Data Fig. 1c) analyses of U251 cells revealed that about 1-1.6% of total OGDH, DLST, and DLD was loca lized in the nucleus (Extended Data Fig. 1b) . About 13-16% of nuclear α -KGDH bound to KAT2A (Extended Data Fig. 1d , top), whereas about 2.3% of KAT2A (Extended Data Fig. 1d , bottom), which was found in nuclei but not in mitochondria (Extended Data Fig. 1e , f), interacted with OGDH.
To determine which component of the α -KGDH complex binds to KAT2A, we depleted individual components of α -KGDH in U251 cells (Fig. 1c, top) and incubated an immunoprecipitated α -KGDH complex depleted of different components with purified His-KAT2A. Immunoblotting analyses demonstrated that OGDH depletion, which did not affect the interaction between DLST and DLD (Extended Data Fig. 1g ), abolished the interaction between KAT2A and the DLST-DLD complex (Fig. 1c, bottom) . By contrast, depletion of DLST or DLD had no effect on the binding of OGDH to KAT2A (Fig. 1c, bottom) . Co-immunoprecipitation analyses showed that OGDH depletion disrupted the association of endogenous KAT2A with the DLST-DLD complex in U251 cells (Extended Data Fig. 1g ). These results suggest that OGDH binds to KAT2A.
We next used NLStradamus software 8 to analyse the amino acid sequences of OGDH, DLST, and DLD and found a putative nuclear localization sequence (NLS) in DLST. We mutated the Arg224 and Lys226 residues in the putative NLS into alanine and glutamic acid, respectively, and found that expression of the DLST(R224A/K226E) mutant reduced nuclear accumulation of the α -KGDH complex (immunofluorescence analyses, Extended Data Fig. 1h ; cell fractionation, Fig. 1d and Extended Data Fig. 1i ). These results indicate that Arg224 and Lys226 in the NLS of DLST are essential for nuclear translocation of the α -KGDH complex.
To understand the nuclear function of the α -KGDH complex, we investigated whether the nuclear α -KGDH complex, which generates succinyl-CoA, contributes to histone succinylation. As shown in Fig. 2a , expression of DLST(R224A/K226E), which did not alter α -KGDH activity (Extended Data Fig. 2a) , total cellular levels of acetylCoA or succinyl-CoA (Extended Data Fig. 2b ), or total cellular protein succinylation (Extended Data Fig. 2c ), markedly reduced histone H3 succinylation in U251 cells. Given that KAT2A associated (Fig. 1a) and co-localized with α -KGDH and histone H3 (Extended Data Fig. 2d ), we depleted KAT2A in U251 cells; this resulted in an approximately
Letter reSeArCH 35% reduction in histone H3 succinylation and substantial inhibition of histone H3 K9 and K14 acetylation (Fig. 2b) . These results suggest that the nuclear α -KGDH complex and KAT2A are involved in histone H3 succinylation.
Because KAT2A binds to acetyl-CoA and acts as a histone acetyl transferase, we investigated whether KAT2A directly transfers the succinyl group of succinyl-CoA to histone H3. We performed an in vitro succinylation assay and showed that wild-type His-KAT2A, but not heat-inactivated His-KAT2A, succinylated histone H3 (Fig. 2c) . Notably, KAT2A-mediated histone H3 succinylation was inhibited by CoA at high doses (Extended Data Fig. 2e ). These results suggest that CoA competes with succinyl-CoA to bind to KAT2A and that the CoA group in succinyl-CoA is involved in its interaction with KAT2A.
To further understand KAT2A-mediated histone H3 succinylation, we crystallized the catalytic domain of KAT2A (residues 497-662) and its complex with succinyl-CoA. We obtained two crystal forms-P41212 and P213-for the apo and complex forms of KAT2A, respectively. The structures were analysed by molecular replacement with the known structure of the KAT2A-acetyl-CoA complex (Protein Data Bank ID: 1Z4R) 9, 10 . To avoid model bias, we removed the acetyl-CoA moiety from the model for molecular replacement. We refined the final crystal structures to 2.9 Å resolution for the apo protein and 2.3 Å resolution for the complex (Extended Data Table 1 ). The overall structures of apo KAT2A and KAT2A-succinyl-CoA are similar to that of the KAT2A-acetyl-CoA complex, with root-meansquare deviations of 1.38 Å and 1.39 Å, respectively, for 163 common Cα atoms (Fig. 2d) . Succinyl-CoA has a similar chemical structure to acetyl-CoA (Extended Data Fig. 2f ) and uses its CoA moiety to bind to a deep hydrophobic pocket in KAT2A. Superimposition of the apo, succinyl-CoA-bound, and acetyl-CoA-bound structures of KAT2A demonstrated major differences in three loop regions (Fig. 2d) . Notably, loop 2, which connects helices α 1 and α 2 (residues 530-535) was drawn closer to the binding pocket by about 2.2 Å upon binding of either acetyl-CoA or succinyl-CoA (Fig. 2d) . Loop 3, which connects helix α 7 and strand β 7 (residues 639-648), can affect substrate specificity 11, 12 . Compared with acetyl-CoA, succinyl-CoA makes additional Van der Waals interactions with side chains of M534, Y645, and A648 on KAT2A and forms hydrogen bonds with the side chain of Y645 and the main-chain carbonyl of Y613 (Extended Data Fig. 2g ). In particular, the contacts made by the succinyl group with Y645 and A648 push loop 3 of KAT2A outward to a more distant location to accommodate the longer succinyl group (Fig. 2e) . Loop 1, which connects helix α 1 and strand β 1 (residues 507-513), is distant from the active site of KAT2A (Fig. 2d) . Because loop 1 is associated with high-temperature factors in all three structures, we consider this region inherently flexible. Therefore, structural variations in loop 1 do not necessarily correlate with substrate binding.
The contact between succinyl-CoA and loop 3 is closer than that between acetyl-CoA and loop 3 (Fig. 2e) , suggesting that succinyl-CoA binds to KAT2A with a higher affinity than does acetyl-CoA. As expected, mixing purified KAT2A with purified histone H3 in the presence of equal amounts of succinyl-CoA and acetyl-CoA showed that succinyl-CoA markedly inhibited KAT2A-mediated H3K9 acetylation, whereas acetyl-CoA caused a much smaller decrease in KAT2A-mediated histone H3 succinylation (Extended Data Fig. 2h ). In addition, we measured the velocity of enzyme-catalysed reaction at infinite concentration of substrate (V max ) and Michaelis constant (K m ) of the modification of histone H3 by KAT2A in the presence of succinyl-CoA or acetyl-CoA. The K m of KAT2A was lower towards succinyl-CoA than that towards acetyl-CoA, suggesting that KAT2A has a higher binding affinity for succinyl-CoA than for acetyl-CoA (Extended Data Fig. 2i ). In addition, KAT2A succinylated histone H3 with a 20% higher velocity than that with which it acetylated histone H3 (Extended Data Fig. 2j ). Disruption of the interaction between succinyl-CoA and Y645 in KAT2A by mutating Y645 to alanine reduced the binding ability and catalytic activity of KAT2A towards succinyl-CoA but not towards acetyl-CoA (Extended Data Fig. 2i ). Consistent with these in vitro results, reconstituted expression of the KAT2A(Y645A) mutant in U251 cells with depleted endogenous KAT2A, which did not affect histone H3 K14 acetylation, reduced histone H3 succinylation when compared with reconstituted expression of wild-type KAT2A (Fig. 2f) . These results indicate that Y645 in KAT2A binds specifically to succinyl-CoA and contributes to enhanced binding of KAT2A to succinyl-CoA.
By comparing the structure of the KAT2A-succinyl-coA complex to that of Tetrahymena thermophila KAT2A (ttKAT2A) in complex with a peptide-CoA bisubstrate 13 , we found that the succinyl group partially occupies the binding site of the lysine substrate (Extended Data  Fig. 2g ). Similar stereochemical conflicts were also noted in the structures of KAT2A in complex with propionyl-CoA and butyryl-CoA 14 . We hypothesize that during catalysis, the acyl chain flips from the binding pocket (Fig. 2d, e Data Fig. 2g, k, cyan) . This situation is similar to that of EP300 15 (also known as p300), a HAT from the GNAT superfamily that catalyses the transfer of acetyl and small hydrophobic acyl groups to histone H3. Although EP300 can use a few acyl-CoA groups, its activity gets weaker with increasing acyl chain length 16 , possibly owing to the size and hydrophobic nature of the flip pocket that excludes long-chain and charged acyl-CoA (for example, succinyl-CoA) variants. As expected, 
Figure 1 | KAT2A interacts with the α-KGDH complex in the nucleus. a-d, Immunoblotting analyses were performed with the indicated antibodies. Representative images of triplicate experiments are shown. a, KAT2A binds to the α -KGDH complex. Immunoprecipitation analyses of U251 cells with an anti-KAT2A antibody were performed. KAT2A-associated proteins were analysed by immunoblotting. b, Nuclear localization of α -KGDH. Immunoblotting analyses of α -KGDH subunits in extracted nuclei of U251 cells were performed. c, OGDH binds to KAT2A. The α -KGDH complex in U251 cells with or without depletion of OGDH, DLST, or DLD using short hairpin RNA (shOGDH, shDLST or shDLD, respectively) was immunoprecipitated with the indicated antibodies and incubated with bacterially purified full-length His-KAT2A protein. d, DLST is required for nuclear distribution of the α -KGDH complex. DLST was depleted from U251 cells, which were reconstituted with expression of RNA interference-resistant (r) wild-type (WT) V5-rDLST or V5-rDLST(R224A/K226E) mutant (V5-rDLST NLS mut). Immunoblotting analyses were performed. Mitochondrial COX IV and IDH2 and nuclear proliferating cell nuclear antigen (PCNA) were used as controls.
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We performed mass spectrometric analyses of KAT2A-succinylated histone H3 and found that H3K79 was succinylated (Extended Data Fig. 3a) . H3K79 succinylation, which was also detected by a specific antibody (Extended Data Fig. 3b) , was blocked by mutating K79 into arginine (Fig. 3a) . Consistent with this finding, histone H3K79 succinylation was identified in U87 and U251 cells by immunoblotting (Fig. 3b) and mass spectrometric analyses (Extended Data Fig. 3c ), and this succinylation was reduced by KAT2A depletion (Fig. 3b and Extended Data Fig. 3d ), but not EP300 depletion (Extended Data  Fig. 3e ). However, quantification of succinyl-CoA and acetyl-CoA revealed that the nucleus contains much less succinyl-CoA than acetyl-CoA in both U87 and U251 cells (Extended Data Fig. 3f ). Because KAT2A interacts with the α -KGDH complex in the nucleus, we hypothesized that succinyl-CoA generated by this complex serves as a local source of succinyl-CoA for KAT2A-dependent histone succinylation. To test this hypothesis, we performed an in vitro succinylation assay by mixing purified KAT2A, histone H3, NAD + , α -KG and CoA in the presence of immunoprecipitated wild-type OGDH or inactive OGDH(P459A/Y460A), which has lost its enzymatic activity (Extended Data Fig. 3g ). We showed that only KAT2A coupled with wild-type OGDH succinylated H3K79 (Fig. 3c) , and this succinylation was observed even in the presence of a high concentration of acetyl-CoA (Extended Data Fig. 3h ). In addition, immunoprecipitated KAT2A from the nuclei of 293 cells expressing wild-type DLST but not DLST(R224A/K226E) succinylated purified histone H3 in the presence of α -KG and absence of exogenous succinyl-CoA (Extended Data  Fig. 3i ). Consistent with this finding, reconstituted expression of the DLST(R224A/K226E) mutant reduced H3K79 succinylation by about 70%, but did not reduce H3K9 or H3K14 acetylation (Fig. 3d) . These results indicate that nuclear α -KGDH couples with KAT2A to mediate H3K79 succinylation.
KAT2A in the SPT-ADA-KAT2A-acetyltransferase (SAGA) complex functions as a HAT, and disruption of this complex inhibits histone acetylation 6 . Depletion of TAF9 RNA polymerase II, which is a core component of the human SAGA complex that is required for its function 6 , reduced acetylation of histone H3K9 and H3K14 without affecting succinylation of H3K79 (Extended Data Fig. 3j) . Thus, in different complexes, KAT2A functions as either a HAT or a succinyltransferase.
To assess the chromatin occupancy of H3K79 succinylation and its correlation with KAT2A at a high resolution, we performed chromatin immunoprecipitation-sequencing (ChIP-seq) assays. We identified 17,107 H3K79 succinylation-enriched peaks, 12,505 KAT2A-bindingenriched peaks, and 249 α -KGDH-binding-enriched peaks, which were widely distributed in the genome of U251 cells. Compared with the non-repetitive genome background, the ChIP-seq peaks for H3K79 succinylation (50.6%), KAT2A-binding (26.8%), and α -KGDH-binding (84.3%) were enriched in the gene promoter regions (Extended Data  Fig. 3k) , and the average distributions of H3K79 succinylation, KAT2A, and α -KGDH in the promoter regions were strongly enriched at transcription starting sites (TSSs) and adjacent regions within 2 kb (Fig. 3e) . We identified 7,186 H3K79-succinylated (Supplementary Table 2 in ribbons, succinyl-CoA in red sticks, and acetyl-CoA in blue sticks. The three loop regions are highlighted, with the apo structure in green, KAT2A-acetyl-CoA complex in blue, and KAT2A-succinyl-CoA complex in red. The rest of the structures are shown in white, grey, and black for apo, the KAT2A-acetyl-CoA complex, and the KAT2A-succinyl-CoA complex, respectively. The three loops, secondary structure elements, and the N and C termini of KAT2A are labelled. The two extra carbons in the succinyl group compared to the acetyl group are highlighted with red dashes. e, Interactions between succinyl-CoA and loop 3 of KAT2A. KAT2A is rainbow-coloured, with the N terminus in blue and the C terminus in red. Tyr645, Ala648, and the succinyl-CoA molecule are shown as sticks. f, KAT2A Y645 is critical for histone H3 succinylation. U251 cells with depleted endogenous KAT2A and reconstituted expression of wild-type Flag-rKAT2A or Flag-rKAT2A(Y645A) were analysed by immunoblotting assay.
Letter reSeArCH promoters only at the point when KAT2A binds to histone H3 (a similar situation also applies for α -KGDH). By contrast, H3K79 succinylation is relatively stable and can be accumulated. This assumption was supported by results showing that the purified KAT2A that was pulled down by immobilized and biotin-labelled nucleosome was dissociated from the immobilized nucleosome and succinylated K79 of histone H3 from purified and soluble nucleosomes (Extended Data Fig. 3m) . A high percentage of α -KGDH-binding peaks (198 of 228, 86.8%) overlapped with peaks of H3K79 succinylation (Supplementary Table 6 ), suggesting that α -KGDH has a critical role in H3K79 succinylation. In addition, 59 (25.9%) of the α -KGDH-bounded-promoters were co-occupied by KAT2A (Supplementary Table 7 ), suggesting that α -KGDH and KAT2A dissociate from histone with differing dynamics. To further support the idea that KAT2A is instrumental in H3K79 succinylation, we showed that KAT2A depletion resulted in a 96% decrease in H3K79 succinylation-enriched gene promoters (Extended Data Fig. 3n , Supplementary Table 8) .
We next used gene set enrichment analysis (GSEA) to examine genes with H3K79 succinylation in their promoter regions for 1,329 canonical pathways defined from various databases. H3K79-succinylated genes were significantly enriched in 130 of 1,329 cell signalling pathways (P < 0.001, FDR q < 0.001) (Extended Data Fig. 4 ). Hypergeometric tests on RNA sequencing (RNA-seq) data revealed that important cell signalling pathways, such as the phosphoinositide 3-kinase (PI3K), activator protein 1 (AP1), and cell cycle pathways, were significantly suppressed by the expression of V5-tagged shRNA-resistant rDLST(R224A/K226E) (V5-rDLST(R224A/ K226E)) or Flag-rKAT2A(Y645A) mutants (P < 0.01, FDR q < 0.05) (Extended Data Fig. 5a-c ). In addition, PIK3R1 (encoding PI3K regulatory subunit alpha, also known as p85α ), JUN (encoding c-Jun), and PRKDC (encoding DNA-dependent protein kinase, catalytic subunit, also known as DNA-PKcs) were among those genes with the most significantly changed expression, the most important regulators in the significantly enriched pathways (P < 0.01, FDR q < 0.05), or important hitches (critical genes involved in the function of multiple signalling pathways) between these pathways. KAT2A depletion significantly reduced succinylation in these selected gene promoter regions (P < 0.01) (Fig. 3f) . Consistently, the mRNA (Extended Data Fig. 5d and 5e) and protein ( Fig. 3g and 3h ) expression of these genes in U87 cells was inhibited by reconstituted expression of FlagrKAT2A(Y645A) or V5-rDLST(R224A/K226E). Similar inhibition was also observed in U251 cells (Extended Data Fig. 5f -i). Together, these results strongly suggest that the α -KGDH complex, associated with KAT2A in gene promoter regions, plays an instrumental role in the regulation of gene expression.
H3K79 succinylation occurred in 7,186 genes, and is therefore likely to affect many cellular activities and cell growth. Reconstituted expression of Flag-rKAT2A(Y645A) and V5-rDLST(R224A/K226E) inhibited proliferation of both U87 ( Histone modifications play critical roles in the regulation of gene expression 6 . We have shown that the α -KGDH complex interacts with KAT2A in the nucleus. This enables KAT2A to access the concentrated succinyl-CoA generated locally by the α -KGDH complex and thereby compensates for the low concentration of succinyl-CoA in the nucleus. Structural analyses demonstrated that the succinyl group of succinyl-CoA protrudes to the very end of a flexible loop 3 to interact specifically with Y645 in loop 3, leading to increased binding of succinyl-CoA (over acetyl-CoA) to KAT2A. The high binding affinity of succinyl-CoA and high local concentrations of succinyl-CoA generated by the KAT2A-associated α -KGDH complex facilitated histone e, Average genome-wide occupancies of H3K79 succinylation (red), KAT2A (blue), and α -KGDH (OGDH, black) around the transcription start site (TSS). f, KAT2A promotes H3K79 succinylation at the indicated gene promoters. ChIP assay with an anti-H3K79 succinylation antibody and quantitative PCR with primers against the promoter regions of PIK3R1, JUN, and PRKDC in U251 cells with or without KAT2A depletion were performed. Two-sided t-test analyses were conducted. The data are presented as the means ± s.d. of three independent experiments (n = 3). * P < 0.05. g, h, α -KGDH-coupled KAT2A regulates gene expression. Protein expression levels of PIK3R1, JUN, and PRKDC in U87 cells with depleted endogenous KAT2A and reconstituted expression of wild-type Flag-rKAT2A or Flag-rKAT2A(Y645A) (g) or with depleted endogenous DLST and reconstituted expression of wild-type V5-rDLST or V5-rDLST NLS mutant (h) were determined by immunoblotting analyses.
Letter reSeArCH succinylation in spite of the relatively low concentration of succinyl-CoA in the nucleus. Thus, KAT2A, as well as being a HAT, is also a histone succinyltransferase; these findings underscore the importance of the coupling of the metabolic enzyme complex α -KGDH and KAT2A for gene expression, tumour cell proliferation, and tumour formation.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment, unless otherwise stated. Materials. The antibodies used in the experiments are listed in Supplementary 3) open reading frame was cloned into the pET32a vector. The pET28a-LIC-KAT2A core domain (encoding residues 47-210) was obtained from Addgene (plasmid #25482). pcDNA6V5HisB-DLST(R224A/K226E), pcDNA3.1/ hygro(+ )-Flag-KAT2A(Y645A), and pET32a-H3(K79R) were made by using a QuikChange site-directed mutagenesis kit (Stratagene).
A control pGIPZ vector was generated by using the control oligonucleotide GCTTCTAACACCGGAGGTCTT. pGIPZ KAT2A shRNA was generated with GCATTAAAGCAGCGTATC. pGIPZ OGDH shRNA was generated with CATCTACCACTTGCAATTA. A control pLKO-1 vector was generated with the control oligonucleotide CCGCAGGTATGCACGCGT. pLKO-1 OGDH (TRCN0000028580), DLST (TRCN0000344818), DLD (TRCN0000275684), and TAF9 (TRCN0000014568) shRNAs were obtained from Sigma-Aldrich. Mass spectrometric analysis. To identify KAT2A-dependent succinylation of lysines on histone H3, an in vitro KAT2A-succinylated sample of purified histone H3 was exhaustively acetylated with acetic anhydride and triethylamine in acetonitrile, evaporated to dryness, and resuspended in 50 mM ammonium bicarbonate buffer containing RapiGest (Waters Corporation). The sample was heated to 95 °C for 10 min and then allowed to cool; 100 ng of sequencing-grade modified trypsin (Promega) was then added to the sample. Digestion of the sample took place overnight at 37 °C and was analysed using LC-MS/MS with an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific). Proteins were identified via a database search of the fragment spectra against the national Swiss-Prot protein database (European Bioinformatics Institute) by using the Mascot software program (version 2.3; Matrix Science) and the SEQUEST software program (version 1.20) via Proteome Discoverer (version 1.3; Thermo Fisher Scientific). Specific succinylated H3 lysine identification was conducted as described previously 2 .
To identify the KAT2A-interacting proteins, KAT2A and its interacting proteins were immunoprecipitated from U251 cells. The protein sample was heated to 95 °C in the presence of SDS-PAGE loading buffer for 10 min and then allowed to cool. The heated sample was loaded into and accumulated in an SDS-PAGE stacking gel via electrophoresis at 100 V for 5 min. Gel band samples were subjected to in-gel digestion, as described previously 3 , and then analysed using LC-MS/MS with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific) interfaced with a Dionex UltiMate 3000 Binary RSLCnano System. The raw data files were processed using the Proteome Discoverer software program (version 1.4), and the International Protein Index database was searched for spectra by using the Mascot software program (version 2.3.02) on an in-house server. Search results were trimmed to a 1% false discovery rate using the Percolator algorithm (Matrix Science). Transfection. Cells (4 × 10 5 ) were cultured in a 60-mm dish for 18 h and then transfected using PolyJet in vitro DNA transfection reagent (SignaGen Laboratories) according to the manufacturer's instructions. Nuclear fractionation analysis. Nuclei from U87 or U251 cells were obtained using a Nuclei Pure Prep Nuclei Isolation Kit from Sigma-Aldrich according to the manufacturer's guidelines.
Histone extraction. Cells were collected and washed twice with ice-cold PBS, then resuspended in triton extraction buffer (TEB: PBS containing 0.5% Triton X-100 (v/v), 2 mM phenylmethylsulfonyl fluoride (PMSF), 0.02% (w/v) NaN 3 ) at a cell density of 10 7 cells per ml. Cells were then lysed on ice for 10 min with gentle stirring and centrifuged at 2,000 r.p.m. for 10 min at 4 °C. The supernatant was removed and discarded. The cells were washed with TEB and centrifuged as before, and then the pellet was resuspended in 0.2 N HCl at a cell density of 4 × 10 7 cells per ml. Histones were acid extracted overnight at 4 °C. Then, samples were centrifuged at 2,000 r.p.m. for 10 min at 4 °C. The supernatant was removed and protein content determined using the Bradford assay, and pH was neutralized by adding 10% (v/v) 2 M NaHCO 3 . Aliquots were stored at − 20 °C. Immunofluorescent microscopic analysis. Cells were seeded on coverslips 24 h before fixation for immunofluorescent assays. The cells were washed three times in PBS (5 min per wash) and then fixed and permeabilized in a freshly prepared mixture of methanol and acetone (80:20) for 10 min at − 20 °C. The cells were then washed three times in cold PBS as before. Cells were blocked for 1 h in a blocking solution (3% bovine serum albumin and 1% horse serum) at 25 °C. Primary antibodies diluted at 1:100 in a blocking solution were added and the mixture was incubated overnight at 4 °C. The cells were again washed three times in PBS. Secondary antibodies diluted at 1:2,000 in a blocking solution were added and the mixture incubated for 1 h at room temperature. Once more, the cells were washed three times in PBS. ProLong Gold antifade reagent with DAPI medium was added. The slides containing the cells were allowed to sit for 10 min in the dark. The coverslips were sealed with a nail hardener. Immunofluorescent microscopic images of the cells were obtained and viewed with an IX81 confocal microscope system (Olympus America). Cell proliferation assay. A total of 5 × 10 4 cells were plated and counted 9 days after seeding in Dulbecco's modified Eagle's medium with 10% bovine calf serum. Data are presented as the means ± s.d. from three independent experiments. Immunoprecipitation and immunoblotting analysis. Proteins were extracted from cultured cells using a modified buffer, and immunoprecipitation and immunoblotting analyses with corresponding antibodies were performed as described previously 3 . A lysis buffer with 0.2% Triton X-100 was used for immunoprecipitation of Flag-rKAT2A expressed in HEK-293 cells. The peptide of H3K79 (EIAQDFKTDLRFQ) was added in the antibody to histone H3K79 succinylation (5 μ g ml ) to further enhance the specificity. The intensities of immunoblotting analyses were measured using ImageJ software. Expression and purification of recombinant proteins. Full-length His-KAT2A and the His-KAT2A catalytic domain were expressed in BL21 strain of Escherichia coli. The cultures grew at 37 °C to an optical density (at a wavelength of 600 nm) of about 0.6 and were then treated with 0.5 mM isopropyl β -d-1-thiogalactopyranoside (IPTG) at 18 °C. Cell pellets were collected, resuspended in BugBuster lysis buffer (EMD Millipore) with a supplement of cocktail proteinase inhibitors and DNase I, and processed using sonication. Soluble His-tagged proteins were purified by using the ÄKTA system with 5 ml of a HisTrap column (GE Healthcare Life Sciences), as described previously 9 . The protein purity was identified via gel staining with GelCode Blue Staining. Crystallization and structure determination. The purified recombinant KAT2A catalytic domain was dialysed with 20 mM HEPES-NaOH (pH 7.5) and 150 mM NaCl and concentrated to 4 mg ml −1 for crystallization. For co-crystallization, 10 mM succinyl-CoA was added to the protein solution. Prism-shaped crystals appeared within 1 day in hanging drops containing 1.5 μ l protein solution and 0.5 μ l mother liquor (in 0.1 M sodium acetate, pH 4.6, and 1.4 M ammonium sulphate or 0.5 M lithium chloride and 1.2 M ammonium sulphate). Crystals usually grew to full size within 7 days. KAT2A crystals were frozen in mother liquor substituted with 25% glycerol. X-ray diffraction data on the crystals were collected at 77 K by the Life Sciences Collaborative Access Team at the Advanced Photon Source. Data for the apo structure were collected at a wavelength of 0.97872 Å at Beamline 21-ID-F; data for the succinyl-CoA complex were collected at a wavelength of 0.97857 Å at Beamline 21-ID-G. One crystal was used for each structure, and values in parentheses (Extended Data Table 1 ) are for highest-resolution shell. Diffraction images were processed using HKL-2000 software. For structure determination, the human KAT2A-acetyl-CoA complex structure (Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank ID: 1Z4R) was used for molecular replacement. The acetyl-CoA ligand was removed from the model to reduce model bias. Molecular replacement was calculated using the Phaser software program in the PHENIX software suite 17 . The structure models were then manually adjusted using the Coot software program 18 and refined using PHENIX. The final coordinates of apo KAT2A have a MolProbity overall score of 1.80 and a clash score of 12.23, with 96.79% favoured, 3.21% allowed and no outlier in the Ramachandran plot, 0.32% rotamer outlier and no Cβ deviation. The final coordinates of succinyl-CoA complex have a MolProbity overall score of 1.40 and a clash score of 7.08, with 98.64% favoured, 1.36% allowed and no outlier in the Ramachandran plot, no rotamer outlier or Cβ deviation. Structure figures were prepared using the PyMOL molecular graphics system (version 1.2r3pre). The coordinates have been deposited at the RCSB Protein Data Bank under accession numbers 5TRM and 5TRL for the apo and succinyl-CoA structures, respectively. In vitro α-KGDH enzymatic activity assay. Immunoprecipitated Flag-tagged α -KGDH from 293 cells was incubated with the α -KGDH buffer (50 mM MOPS HCl, pH 7.4, 0.2 mM MgCl 2 , 0.01 mM CaCl 2 , 0.3 mM cocarboxylase, 0.12 mM CoA, 2 mM β -nicotinamide adenine dinucleotide, 2.6 mM l-cysteine) and 5 mM α -ketoglutarate at 30 °C for 30 min. At the end of the reaction, 10 U diaphorase and 20 μ M resazurin were added to generate a fluorescent signal in proportion to the amount of NADH generated by α -KGDH. The α -KGDH enzyme activity was measured via direct coupling of the NADH production with conversion of resazurin to resorufin by diaphorase. Resorufin was measured fluorometrically at an excitation wavelength of 544 nm and emission wavelength of 590 nm. Data are presented as the means ± s.d. of three independent experiments. In vitro histone H3 succinylation assay. To analyse KAT2A-catalysed histone H3 succinylation, we incubated purified wild-type His-histone H3 or His-histone H3(K79R) with purified full-length active KAT2A in the presence of HAT buffer (50 mM Tris-HCl, pH 8.0, 50 mM KCl, 5% glycerol, 0.1 mM EDTA, 1 mM dithiothreitol, 1 mM PMSF, 10 mM sodium butyrate) and 2 μ M succinyl-CoA at 37 °C for 10 min. Histone H3 succinylation was determined by using immunoblotting analysis.
To analyse α -KGDH-dependent histone H3 succinylation, we incubated the immunoprecipitated Flag-tagged OGDH from 293 cells with purified wild-type histone H3, full-length active KAT2A, and 5 mM α -ketoglutaric acid in the presence of α -KGDH buffer (50 mM MOPS HCl, pH 7.4, 0.2 mM MgCl 2 , 0.01 mM CaCl 2 , 0.3 mM cocarboxylase, 0.12 mM CoA, 2 mM β -nicotinamide adenine dinucleotide, 2.6 mM l-cysteine) at 30 °C for 30 min. Histone H3 succinylation was determined with use of immunoblotting analysis.
To analyse nuclear α -KGDH-KAT2A complex-dependent histone H3 succinylation, we transfected the vector expressing wild-type Flag-rKAT2A with the vector expressing wild-type V5-rDLST or the V5-rDLST NLS mutant. The nuclear α -KGDH-KAT2A complex was immunoprecipitated with anti-Flag agarose beads. Purified wild-type histone H3, nuclear α -KGDH-KAT2A complex, and 5 mM α -ketoglutaric acid were incubated in the presence of α -KGDH buffer at 30 °C for 3 h. Histone H3 succinylation was determined by using immunoblotting analysis. Steady-state kinetics of KAT2A activity for histone H3 modifications. The reaction mixture was precipitated via centrifugation at 1,000g for 5 min. The production of CoA in the supernatant was quantitatively analysed using a modified protocol from the PicoProbe Acetyl-CoA Fluorometric Assay Kit (BioVision). In brief, 25 μ l supernatant was mixed with 1 μ l PicoProbe, 1 μ l acetyl-CoA substrate mix, 2.5 μ l acetyl-CoA enzyme mix, and 20.5 μ l acetyl-CoA assay buffer. The CoA can react to form NADH, which interacts with OicoProbe to generate fluorescence (E x /E m = 535/587 nm). An identical reaction was set up for each acetyl-CoA or succinyl-CoA titration without KAT2A protein and used as the blank control. Data are presented as the means ± s.d. of three independent experiments. Quantitative analysis of nuclear succinyl-CoA and acetyl-CoA. The nuclei were obtained from U251 and U87 cells and analysed using LC-MS/MS. In brief, nuclear extracts were processed for protein precipitation followed by solid-phase extraction. Fifteen per cent trichloroacetic acid (TCA) in water was applied to remove proteins and other interference substances from the nuclear samples. The supernatant was subsequently transferred to a Waters HLB solid-phase extraction cartridge for further sample clean-up. The final reconstitution samples were injected into a Gemini C6-phenyl 100 × 4.6 mm 3 μ M high-performance liquid chromatography column (Phenomenex). The mobile phase consisted of ammonium acetate and acetic acid in both aqueous and organic phases. Data acquisition was performed using a 6460 Series Triple Quadrupole LC/MS (Agilent Technologies) via multiple reaction mode (MRM) electrospray positive mode. Quantitative real-time PCR. Total RNA of cells was extracted using an RNeasy Plus Kit (QIAGEN). cDNA was prepared using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative real-time PCR analysis was performed by using 2 × iQ SYBR Green Supermix (Bio-Rad) in the following conditions: 5 min at 95 °C, and then 40 cycles at 95 °C for 30 s, 58 °C for 20 s, and 72 °C for 15 s using a Bio-Rad CFX96 Real-Time System. Data were normalized according to expression of a control gene (ACTB) in each experiment. The data are presented as the means ± s.d. from three independent experiments.
The following primer pairs were used for quantitative real-time PCR: PIK3R1, 5′ -GGGTGAAGCTCGTGTGTGGA-3′ (forward) and 5′ -GTGTGACCGAAGAC AGGGCT-3′ (reverse); JUN, 5′ -TCTGGGAAGTGAGTTCGCCT-3′ (forward) and 5′ -ATGCCTCCCGCACTCTTACT-3′ (reverse); PRKDC, 5′ -AGGCGGCT TACCTGAGTGAT-3′ (forward) and 5′ -CACGAAGGCCCGCTTTAAGA-3′ (reverse); and ACTB, 5′ -CATCGAGCACGGCATCGTCA-3′ (forward) and 5′ -TAGCACAGCCTGGATAGCAAC-3′ (reverse). ChIP and ChIP-seq assay. ChIP was performed using a SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology). Chromatin prepared from cells in a 15-cm dish was used to determine total DNA input and was incubated overnight with specific antibodies or normal rabbit IgG. The following primer pairs were used for candidate gene promoter region validation: PIK3R1, 5′ -CCGGCGTCCTGTGAG ATCC -3′ (forward) and 5′ -GCAACTCCGGGGGCAAATG-3′ (reverse); JUN, 5′ -AGTTCAACAACCGGTGCGAG-3′ (forward) and 5′ -AGAGTCCCGGA GCCAACTTT-3′ (reverse); and PRKDC, 5′ -GGAGCCGGTGTGCGTTG-3′ (forward) and 5′ -GGCCGCGGATCAGTTGATGA-3′ (reverse).
ChIP sequencing was performed at the Sequencing and Microarray Facility at The University of Texas MD Anderson Cancer Center. In brief, indexed libraries were prepared from 20 ng Bioruptor-sheared (Diagenode) ChIP DNA using a Hyper Library Preparation Kit (Kapa Biosystems). The libraries were amplified using three cycles of PCR and then assessed for quality using a Fragment Analyzer High Sensitivity NGS Fragment Analysis Kit (Advanced Analytical Technologies) and quantified using a Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific). The indexed libraries were pooled at three libraries per pool and sequenced in one lane of a HiSeq2000 Sequencer (Illumina) using the 36-nt single-read configuration. RNA-seq. Total RNA was extracted from cells using a PureLinkTM RNA Mini Kit (Thermo Fisher Scientific). Illumina compatible libraries were prepared using the KAPA Stranded mRNA-Seq Library Preparation Kit for Illumina platforms (KAPA Biosystems). In brief, 250 ng total RNA was enriched for poly-A-tailed mRNA using Kapa's mRNA Capture beads. Poly-A-enriched RNA was fragmented to a median size of 150 bp using chemical fragmentation and converted into double-stranded cDNA with dUTP incorporated into the second cDNA strand. The ends of the double-stranded cDNA were polished, 5′ -phosphorylated, and 3′ -A-tailed for the ligation of indexed adaptors. Adaptor-ligated DNA fragments were amplified by eight cycles of PCR. The strand with incorporated dUTP was not amplified. The resulting libraries were quantified by qPCR and assessed for size distribution using the 4200 TapeStation (Agilent Technologies), and then multiplexed (four per pool) and sequenced on the Illumina's NextSeq500 using the mid-output, 75-bp paired-end read format. Analyses of RNA-seq and ChIP-seq data. We used a series of cutoffs to analyse the RNA-seq and ChIP-seq data and selected the genes that met the following two criteria: 1) expression that was significantly altered by either KAT2A(Y645A) or DLST(R224A/K226E) mutant expression (P < 0.05 and FDR q < 0.1 in the RNAseq data); and 2) enriched H3K79 succinylation in promoter regions (fold enrichment > 2 and FDR q < 0.1 in the ChIP-seq data). Gene set enrichment and pathway analyses. GSEA of the results from nextgeneration sequencing data was performed using GSEA v2.2.3 software with the gene lists for 1,329 canonical pathways in collection C2.CP from Molecular Signature Database (MSigDB) V5.2. Both the GSEA software and the MSigDB are maintained by the Broad Institute. Collection C2.CP includes curated pathway maps from multiple established pathway databases, including REACTOME, KEGG, BIOCARTA, PANTHER and Pathway Interaction Database (PID).
GSEA of the ChIP-seq data was based on the fold-enrichment (FE) measurement for 20,338 genes by using the 'GSEA preranked' option.
GSEA results were visualized using the EnrichmentMap v2.0.1 plugin in the Cytoscape v3.2.1 network visualization platforms.
Hypergeometric tests were used to identify pathways enriched with significantly altered genes. We used the ConsensusPathDB-human (CPDB) platform developed at the Max Planck Institute for Molecular Genetics, which contains 5,068 canonical pathways defined in 12 public sources (including KEGG, REACTOME, BIOCARTA, PID, WikiPathways, and NetPath).
significance of a certain number (k) of pathways grouped from the genes with significant expression changes (n, the number of genes that meet the criteria of P < 0.05 and q < 0.1 for RNA-seq; fold enrichment > 2 and q < 0.1 for ChIP-seq). N represents the total number of genes identified in both the ChIP-seq and RNAseq analyses. K represents the number of member genes identified in both the RNA-seq and ChIP-seq analyses, and k represents the number of genes from each K that passed the significance cutoff (P < 0.05 and q < 0.1 for RNA-seq; fold enrichment > 2 and q < 0.1 for ChIP-seq). We calculated the P value P (X ≥ k) as the Letter reSeArCH probability of randomly drawing k or more genes from the gene population (n) that passed the cutoff for significant changes in expression. We selected pathways with P < 0.01 and FDR q < 0.05 to be candidates for follow-up studies. We performed visualization revealing the relationship of the selected genes with 10 critical pathways using the EnrichmentMap v2.0.1 plug-in in the Cytoscape v3.2.1 network visualization platform. Intracranial injection. U87 cells (5 × 10 5 ) with or without modified gene expression were intracranially injected into female 4-week-old athymic nude mice (in 5 μ l of Dulbecco's modified Eagle's medium per mouse), as described 3 . Five mice were randomly grouped before tumour cell injection. The mice were killed 30 days after injection. The brains were removed, fixed in 4% formaldehyde, and embedded in paraffin. Tumour formation was determined by haematoxylin and eosin staining. d, Quantitative analyses of the interaction between KAT2A and α -KGDH subunits. Immunoprecipitation analyses of U251 cell nuclei with anti-KAT2A or anti-OGDH antibodies were performed. KAT2A-or OGDH-associated proteins were analysed via immunoblotting analyses. Representative images of triplicate experiments are shown. e, f, KAT2A is not localized in mitochondria. e, Immunoblotting analyses of the mitochondria extraction and total cell lysate of U251 cells were performed with the indicated antibodies. Representative images of triplicate experiments are shown. f, Immunofluorescent analyses of U251 cells were performed with DAPI (blue) and anti-KAT2A (green) and anti-TOM20 (red) antibodies. Representative images of more than 50 cells are shown. g, OGDH depletion, which does not affect the interaction between DLST and DLD, inhibits the binding of DLST to KAT2A. OGDH was depleted in U251 cells. Immunoprecipitation analyses with an anti-DLST antibody were followed by immunoblotting analyses with the indicated antibodies. Representative images of triplicate experiments are shown. h, i, The NLS of DLST is required for nuclear distribution of the α -KGDH complex. DLST was depleted from U87 cells, which were reconstituted with expression of wild-type rDLST or the rDLST(R224A/K226E) NLS mutant. h, Immunofluorescent staining was performed with an anti-DLST or anti-OGDH antibody. The mitochondria and nuclei were stained with an anti-Tom20 antibody (red) and DAPI (blue), respectively. i, Immunoblotting analyses were performed with the indicated antibodies. Mitochondrial COX IV and IDH2 and nuclear PCNA were used to show lack of mitochondrial contamination of nuclear fractions and loading controls. Representative images of triplicate experiments are shown.
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Extended Data Figure 2 | KAT2A associates with α-KGDH and acts as a histone succinyltransferase. a, rDLST NLS mutation does not affect the enzymatic activity of α -KGDH. Wild-type His-rDLST or His-rDLST NLS mutant expressed in 293 cells was precipitated using Ni-NTA agarose beads. The enzymatic activity of α -KGDH was measured. Two-sided t-tests were conducted. The data are presented as the means ± s.d. from five independent experiments (n = 5). b, rDLST NLS mutant expression does not affect cellular levels of acetyl-CoA or succinyl-CoA. The levels of acetyl-CoA and succinyl-CoA in U251 cells with depleted endogenous DLST and reconstituted expression of wild-type V5-rDLST or V5-rDLST NLS mutant were measured by LC-MS/MS. Two-sided t-tests were conducted. The data are presented as the means ± s.d. from three independent experiments (n = 3). c, rDLST NLS mutant expression does not affect total cellular protein succinylation. Lysine succinylation of whole-cell lysate of U251 cells expressing wild-type V5-rDLST or V5-rDLST NLS mutant was analysed by immunoblotting analysis with an anti-succinyl-lysine antibody. The protein levels of each sample were shown by Ponceau S staining. Representative images of triplicate experiments are shown. d, Quantification of the colocalization of KAT2A, α -KGDH complex, and histone H3. Immunofluorescent analyses were performed with anti-DLST (red), anti-KAT2A (blue), and anti-histone H3 (green) antibodies. The Pearson's R value is used to present the extent of co-localization of two different targets. The random co-localization tests were conducted by 90° clockwise rotation of KAT2A (blue channel) and 180° clockwise rotation of histone H3 (green channel). Two-sided t-tests were conducted. Statistical analysis for 79 individual cells (n = 79) was performed. * P < 0.05. e, KAT2A-mediated histone H3 succinylation is inhibited by CoA. KAT2A-mediated histone H3 succinylation was analysed by mixing purified KAT2A, histone H3, and succinyl-CoA Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined. The group sizes of the animals chosen are based on the numbers we used for previous publications, which is most optimal to generate statistically significant results.
Data exclusions
Describe any data exclusions.
No samples or animals were excluded from the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
The number of replications (equal or more than 3 times) of each experiment have been stated in the article.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The samples/cells for IHC studies were randomized to be examined( No specific methods were used). The mice were randomized to put into separate/groups cages for experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were divided into four groups. One group were blinded to allocation during experiments and outcome assessment.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No restrictions on availability of unique materials
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
All the antibodies used are commercially available. Detail information has been included in the supplementary table 9. U251 cell lines used in the experiments is listed in the database of commonly misidentified cell lines maintained by ICLAC. The U251 cells were authenticated by using short tandem repeat profiling.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Female, 4-week-old athymic nude mice were used in the animal studies with the protocol approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center. Detail information has been included in the Materials and Methods.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
No human research participants.
